Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOVO-SALMOL INHALER 100MCG/AEM DIN 00874086

Status: Cancelled Post Market
Holder: NOVOPHARM LIMITED
Molecule: SALBUTAMOL

Health Canada record

Active ingredient(s)SALBUTAMOL 100 MCG
Dosage formMetered-Dose Aerosol
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCR03CC02 SALBUTAMOL
Original market date31-Dec-1991
Current status date10-Aug-2005
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SALBUTAMOL

DINProductCompanyFormStrengthStatus
00790419APO-SALVENT AEM 100MCGAPOTEX INCMetered-Dose AerosolSALBUTAMOL 100 MCGCancelled Post Market
00851841RATIO-SALBUTAMOLRATIOPHARM INC DIVISION OF TEVA CANADA LIMITEDMetered-Dose AerosolSALBUTAMOL 100 MCGCancelled Post Market
00812463SABULIN INHALER 100MCG/METERED DOSE AEROSOLGENPHARM ULCMetered-Dose AerosolSALBUTAMOL 100 MCGCancelled Post Market
02213478VENTOLIN INHALERGLAXOSMITHKLINE INCMetered-Dose AerosolSALBUTAMOL 100 MCGCancelled Post Market
00867179VENTOLIN INHALER 100MCG/AEMGLAXO CANADA INCMetered-Dose AerosolSALBUTAMOL 100 MCGCancelled Post Market

International API supply for SALBUTAMOL

2 active FDA Drug Master Files.

Request a quote for NOVO-SALMOL INHALER 100MCG/AEM

How to read a Canadian DIN record